Tolerance and pharmacokinetics of high doses of interferon-alpha-2a in a hemodialysis patient.
Izzedine
H
H
Department of Nephrology, Pitié-Salpêtrière Hospital, 47-83, boulevard de l'hôpital, F-75013 Paris, France. hassan.izzedine@psl.ap-hop-paris.fr
Lebon
P
P
Launay-Vacher
V
V
Hamani
A
A
Deray
G
G
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007676:Kidney Failure, Chronic / Q000601:surgery / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis
D020533:Angiogenesis Inhibitors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins